SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-21-007747
Filing Date
2021-04-27
Accepted
2021-04-27 16:32:55
Documents
6
Period of Report
2021-04-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A auriniapharmaceuticalsinc2.htm PRE 14A 1688645
2 aurinalogo1a.jpg GRAPHIC 11010
3 infographic31.jpg GRAPHIC 142046
4 proxycard_11.jpg GRAPHIC 127888
5 proxycard_21.jpg GRAPHIC 124158
6 votingmethods1.jpg GRAPHIC 71916
  Complete submission text file 0001628280-21-007747.txt   2320136
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36421 | Film No.: 21859447
SIC: 2834 Pharmaceutical Preparations